Straumann Holding AG Total Current Assets 2012-2021 | SAUHY

Straumann Holding AG total current assets from 2012 to 2021. Total current assets can be defined as the sum of all assets that are classified as current because they will provide a benefit within one year.
  • Straumann Holding AG total current assets for the quarter ending December 31, 2021 were $1.673B, a 113.83% increase year-over-year.
  • Straumann Holding AG total current assets for 2021 were $1.673B, a 36.09% increase from 2020.
  • Straumann Holding AG total current assets for 2020 were $1.229B, a 38.49% increase from 2019.
  • Straumann Holding AG total current assets for 2019 were $0.887B, a 13.45% increase from 2018.
Straumann Holding AG Annual Total Current Assets
(Millions of US $)
2021 $1,673
2020 $1,229
2019 $887
2018 $782
2017 $696
2016 $464
2015 $567
2014 $726
2013 $606
2012 $338
2011 $630
Straumann Holding AG Quarterly Total Current Assets
(Millions of US $)
2021-12-31 $1,673
2020-12-31 $1,229
2020-06-30 $962
2019-12-31 $887
2018-12-31 $782
2017-12-31 $696
2017-06-30 $510
2016-12-31 $464
2016-06-30 $606
2015-12-31 $567
2014-12-31 $726
2013-12-31 $606
2013-06-30 $547
2012-12-31 $338
2012-06-30 $340
2011-12-31 $630
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $23.137B $2.685B
The Straumann Group is a global leader in implant and restorative dentistry and oral tissue regeneration. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs approximately on thousand seven hundred ninety people worldwide and its products and services are available in more than sixty countries through its broad network of distribution subsidiaries and partners.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $76.568B 20.89
Becton Dickinson (BDX) United States $71.603B 18.76
Cardinal Health (CAH) United States $30.919B 16.77
West Pharmaceutical Services (WST) United States $24.592B 50.23
Labcorp (LH) United States $20.594B 17.08
Cooper (COO) United States $19.559B 26.49
Align Technology (ALGN) United States $16.756B 32.06
Henry Schein (HSIC) United States $9.958B 18.97
Merit Medical Systems (MMSI) United States $6.322B 32.29
DENTSPLY SIRONA (XRAY) United States $3.902B 10.61
Patterson (PDCO) United States $2.733B 14.60
CONMED (CNMD) United States $2.174B 18.14
STAAR Surgical (STAA) United States $1.192B 43.98
Lifevantage (LFVN) United States $0.274B 36.50
Pro-Dex (PDEX) United States $0.141B 28.09